Table 1 Demographic and clinical data in patients with JIA and control for TL and JIA and controls for PWV

Age (years)

15,5 ± 6,3

11,4 ± 1,3

0, 005^a

13,8 ± 5,9

0,184^a

Male

7 (26,1)

8 (40,9)

0,460^b

6 (30)

0,458^b

Female

17(73,9)

13 (59,1)

14 (70)

Caucasian

19 (82,6)

17(81,8)

1, 000^c

16 (80)

0,640^c

Black

5 (17,4)

4 (18,2)

4 (20)

Weight (Kg)

50,1 ± 17,5

42,5 ± 10,2

0, 085^a

46,8 ± 13,7

0,528^a

Height (m)

1,52 ± 0,17

1,47 ± 0,09

0, 162^a

1,44 ± 1,09

0,473^a

BMI (KG/m²)

20,7 ± 3,7

19,6 ± 2,7

0, 247^a

18,2 ± 4,9

0,372^a

Duration disease (years) [P25 - P75]

9 [5–19]

Oligoarticular

15 (65,2)

Polyarticular

8 (34,8)

Corticoids

8 (34,8)

NSAIDS

0(0,0)

Methotrexate

12 (52,2)

Leflunomide

10 (43,5)

Anti-TNF

7 (30,4)

Uveitis – n (%)

1 (4,3)